Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Advances in Transversal Topics Applicable to the Care of Bladder Cancer Patients in the Real-World Setting.
Garrido Siles M, López-Beltran A, Pelechano P, García Vicente AM, Gironés Sarrió R, González-Haba Peña E, Rodríguez Antolín A, Zapatero A, Arranz JÁ, Climent MÁ; Spanish Oncology Genitourinary Multidisciplinary Working Group. Garrido Siles M, et al. Among authors: rodriguez antolin a. Cancers (Basel). 2022 Aug 17;14(16):3968. doi: 10.3390/cancers14163968. Cancers (Basel). 2022. PMID: 36010964 Free PMC article. Review.
Consensus statement on definition, diagnosis, and management of high-risk prostate cancer patients on behalf of the Spanish Groups of Uro-Oncology Societies URONCOR, GUO, and SOGUG.
Henríquez I, Rodríguez-Antolín A, Cassinello J, Gonzalez San Segundo C, Unda M, Gallardo E, López-Torrecilla J, Juarez A, Arranz J. Henríquez I, et al. Among authors: rodriguez antolin a. Clin Transl Oncol. 2018 Mar;20(3):392-401. doi: 10.1007/s12094-017-1726-y. Epub 2017 Aug 7. Clin Transl Oncol. 2018. PMID: 28785912
Management of Localized Muscle-Invasive Bladder Cancer from a Multidisciplinary Perspective: Current Position of the Spanish Oncology Genitourinary (SOGUG) Working Group.
Gómez Caamaño A, García Vicente AM, Maroto P, Rodríguez Antolín A, Sanz J, Vera González MA, Climent MÁ, On Behalf Of The Spanish Oncology Genitourinary Sogug Multisiciplinary Working Group. Gómez Caamaño A, et al. Among authors: rodriguez antolin a. Curr Oncol. 2021 Dec 3;28(6):5084-5100. doi: 10.3390/curroncol28060428. Curr Oncol. 2021. PMID: 34940067 Free PMC article. Review.
Focal therapy for prostate cancer. Alternative treatment.
Gómez-Veiga F, Martínez-Breijo S, Solsona-Narbón E, Hernández C, Ciudin A, Ribal MJ, Dickinson L, Moore C, Ahmed H, Rodríguez Antolín A, Breda A, Gaya J, Portela-Pereira P, Emberton M. Gómez-Veiga F, et al. Among authors: rodriguez antolin a. Actas Urol Esp. 2014 Sep;38(7):465-75. doi: 10.1016/j.acuro.2013.12.006. Epub 2014 Mar 4. Actas Urol Esp. 2014. PMID: 24612733 Review. English, Spanish.
Quality of life and adverse events in patients with nonmuscle invasive bladder cancer receiving adjuvant treatment with BCG, MMC, or chemohyperthermia.
González-Padilla DA, González-Díaz A, Guerrero-Ramos F, Rodríguez-Serrano A, García-Jarabo E, Corona-laPuerta M, Rodríguez-Antolín A, Villacampa-Aubá F. González-Padilla DA, et al. Among authors: rodriguez antolin a, rodriguez serrano a. Urol Oncol. 2021 Jan;39(1):76.e9-76.e14. doi: 10.1016/j.urolonc.2020.07.003. Epub 2020 Aug 1. Urol Oncol. 2021. PMID: 32753359
Role of 18F-Choline PET/CT in the Initial Staging of High Risk Prostate Cancer and Comparison with Conventional Imaging Techniques.
Sopeña Sutil R, Gómez Grande A, González Díaz A, Téigel Tobar J, Cabeza Rodríguez MÁ, González Billalabeitia E, Rodríguez Antolín A. Sopeña Sutil R, et al. Among authors: rodriguez antolin a. Arch Esp Urol. 2022 Oct;75(8):684-692. doi: 10.56434/j.arch.esp.urol.20227508.99. Arch Esp Urol. 2022. PMID: 36330569 Free article.
Cystoscopy Real-Time Self-Visualization and Its Impact in Patient's Pain Perception.
González-Padilla DA, González-Díaz A, García-Gómez B, Villacampa-Aubá F, Miranda-Utrera N, Rodríguez-Antolín A, Guerrero-Ramos F. González-Padilla DA, et al. Among authors: rodriguez antolin a. J Endourol. 2019 Apr;33(4):309-313. doi: 10.1089/end.2018.0768. Epub 2019 Mar 21. J Endourol. 2019. PMID: 30793929 Clinical Trial.
New immunotherapies for high-risk non-muscle invasive bladder cancer: Current state and future perspectives.
Gómez Del Cañizo C, Rodríguez-Izquierdo Jiménez M, Peña Vallejo E, Duarte Ojeda JM, de la Rosa Kehrman F, Rodríguez Antolín A, Guerrero Ramos F. Gómez Del Cañizo C, et al. Among authors: rodriguez izquierdo jimenez m, rodriguez antolin a. Actas Urol Esp (Engl Ed). 2020 Nov;44(9):574-585. doi: 10.1016/j.acuro.2020.06.011. Epub 2020 Aug 24. Actas Urol Esp (Engl Ed). 2020. PMID: 32854979 Review. English, Spanish.
Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial.
Guerrero-Ramos F, González-Padilla DA, González-Díaz A, de la Rosa-Kehrmann F, Rodríguez-Antolín A, Inman BA, Villacampa-Aubá F. Guerrero-Ramos F, et al. Among authors: rodriguez antolin a. World J Urol. 2022 Apr;40(4):999-1004. doi: 10.1007/s00345-022-03928-1. Epub 2022 Jan 17. World J Urol. 2022. PMID: 35037963 Free PMC article. Clinical Trial.
124 results